WSI Co., Ltd.

A299170

KR7299170001

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
1,856 ^KRW	-0.22%		-0.80%	-16.21%

2023	WSI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2021	WSI Co., Ltd. announced that it has received KRW 18.3 billion in funding	CI

WSI Co., Ltd. announced that it has received KRW 18.3 billion in funding

July 26, 2021

On July 27, 2021, WSI Co., Ltd. closed the transaction.

Latest news about WSI Co., Ltd.

WSI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
WSI Co., Ltd. announced that it has received KRW 18.3 billion in funding	21-07-26	CI
WSI Co., Ltd. announced that it expects to receive KRW 18.3 billion in funding	21-07-22	CI
WSI Co., Ltd. completed the acquisition of IBKS No.10 Special Purpose Acquisition Company in a reverse merger transaction.	20-11-16	CI
WSI Co., Ltd. agreed to acquire IBKS No.10 Special Purpose Acquisition Company in a reverse merger transaction for KRW 50 billion.	20-06-08	CI

WSI Co Ltd, formerly IBKS No.10 Special Purpose Acquisition Co, is a Korea-based company mainly engaged in the sale of pharmaceuticals and medical devices. The Company mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.

Sector

Pharmaceuticals

Calendar

2024-05-23 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
WSI CO., LTD.	-16.21%	40.27M
MCKESSON CORPORATION	+16.03%	70.59B
CARDINAL HEALTH, INC.	+2.22%	25.06B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+7.11%	8.2B
SINOPHARM GROUP CO. LTD.	-2.98%	7.92B
HUADONG MEDICINE CO., LTD	-20.55%	7.96B
H. LUNDBECK A/S	+3.11%	4.71B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.32B
EBOS GROUP LIMITED	-1.24%	4.01B
GALENICA AG	-3.44%	3.82B